EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS

Corneliu Toader, Calin Petru Tataru, Octavian Munteanu, Matei Serban, Razvan-Adrian Covache-Busuioc, Alexandru Vlad Ciurea, Mihaly Enyedi iD

International Journal of Molecular Sciences · 24.11.2024 · 25 (23) · 12613

DOI: 10.3390/ijms252312613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.11.2024. Verfasst von Corneliu Toader und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Alzheimer Disease, Parkinson Disease, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 486 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, ALS, and Huntington’s, remain formidable challenges in medicine, with their relentless progression and limited therapeutic options. These diseases arise from a web of molecular disturbances—misfolded proteins, chronic neuroinflammation, mitochondrial dysfunction, and genetic mutations—that slowly dismantle neuronal integrity. Yet, recent scientific breakthroughs are opening new paths to intervene in these once-intractable conditions. This review synthesizes the latest insights into the underlying molecular dynamics of neurodegeneration, revealing how intertwined pathways drive the course of these diseases. With an eye on the most promising advances, we explore innovative therapies emerging from cutting-edge research: nanotechnology-based drug delivery systems capable of navigating the blood–brain barrier, gene-editing tools like CRISPR designed to correct harmful genetic variants, and stem cell strategies that not only replace lost neurons but foster neuroprotective environments. Pharmacogenomics is reshaping treatment personalization, enabling tailored therapies that align with individual genetic profiles, while molecular diagnostics and biomarkers are ushering in an era of early, precise disease detection. Furthermore, novel perspectives on the gut–brain axis are sparking interest as mounting evidence suggests that microbiome modulation may play a role in reducing neuroinflammatory responses linked to neurodegenerative progression. Taken together, these advances signal a shift toward a comprehensive, personalized approach that could transform neurodegenerative care. By integrating molecular insights and innovative therapeutic techniques, this review offers a forward-looking perspective on a future where treatments aim not just to manage symptoms but to fundamentally alter disease progression, presenting renewed hope for improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseParkinson DiseaseAmyotrophic Lateral SclerosisHumansAnimalsNeurodegenerative DiseasesDrug Delivery SystemsGene Editing

Stichwörter der Autor:innen

Alzheimer’s disease (AD)Huntington’s disease (HD)Parkinson’s disease (PD)gene therapymitochondrial dysfunctionneuroinflammationpharmacogenomicsprecision medicineprotein misfolding

Autor:innen und Institutionen

  • Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Vascular Neurosurgery, National Institute of Neurology and Neurovascular Diseases, 077160 Bucharest, Romania.
  • Ophthalmology Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Anatomy, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Neurosurgery Department, Sanador Clinical Hospital, 010991 Bucharest, Romania.
  • Medical Section within the Romanian Academy, 010071 Bucharest, Romania.

ORCID-Profile: Mihaly Enyedi

Förderung

  • University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish

Zitieren

APA

Toader, C., Tataru, C. P., Munteanu, O., Serban, M., Covache-Busuioc, R. A., Ciurea, A. V., & Enyedi, M. (2024). Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS. International Journal of Molecular Sciences, 25(23), 12613. https://doi.org/10.3390/ijms252312613

Vancouver

Toader C, Tataru CP, Munteanu O, Serban M, Covache-Busuioc RA, Ciurea AV, et al. Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS. International Journal of Molecular Sciences. 2024;25(23):12613. doi:10.3390/ijms252312613

BibTeX
@article{Toader2024,
  author = {Toader, Corneliu and Tataru, Calin Petru and Munteanu, Octavian and Serban, Matei and Covache-Busuioc, Razvan-Adrian and Ciurea, Alexandru Vlad and Enyedi, Mihaly},
  title = {Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {23},
  pages = {12613},
  doi = {10.3390/ijms252312613}
}
Kostenlos starten →